Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Pfizer
M.D. Anderson Cancer Center
Erasca, Inc.
Sichuan Enray Pharmaceutical Sciences Company
AstraZeneca
Arvinas Inc.
University of Colorado, Denver
Alliance for Clinical Trials in Oncology
Pfizer
xCures
University of Nebraska
Zhejiang University
Adela, Inc
Eli Lilly and Company